JPRN-jRCT2042230116暂停3 期
A phase III sTudy evaluating the efficacy and safety of Trans-Esophageal Motor-evoked PoTential monitoring and the special electrode during aortic surgery - ATTEMPT
orihiko Shiiya0 个研究点目标入组 100 人开始时间: 2023年12月15日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 暂停
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable(—)
- 性别
- All
入选标准
- •1) patients scheduled to undergo aortic surgery carrying the risk of ischemic spinal cord injury and TC-MEP
- •2) patients aged 20 years or more on the day of giving informed consent
- •3) patients giving written informed consent to be enrolled in this trial
排除标准
- •Patients meeting any of the following exclusion criteria on the day of enrollment are excluded.
- •1) patients undergoing aortic surgery within 24 hours after non-scheduled admission
- •2) patients having esophageal abnormality (severe compression or deviation causing esophageal obstruction by tumors or something else, esophageal varices with a arisk of bleeding, esophagus not locating in the normal anatomical position at theT4 level such as post-esophageal surgery, etc)
- •3) patients having head skin abnormality (resulting in difficulty of setting the transcranial stimuation elecrodes) at the stimulation points
- •4) patients having paralysis (such as hemiplegia or paraplegia) or neuromusclar diseases with severe
- •5) patients unable to walk without assistance due to prolonged bed rest or some other reasons
- •6) patients judged unsuitable by the investigators or subinvstigators
研究者
相似试验
尚未招募
3 期
A Phase III Study of CLS2901C in Patients with Osteoarthritis of the KneeOsteoarthritis of the KneeJPRN-jRCT2033230587Saito Yuki96
已完成
不适用
A phase 3 study to determine the efficacy and safety of recombinant human activated protein C in severe sepsisSevere sepsisInfections and InfestationsSepsisISRCTN74215569Eli Lilly and Company (USA)1,690
招募中
3 期
A study to learn more about asundexian for prevention of stroke in male and female participants who already had such a stroke due to a blood clot that formed outside the heart and travelled to the brain, or temporary stroke-like symptoms.CTRI/2024/01/061517Bayer Pharmaceuticals Private Limited
进行中(未招募)
1 期
A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects with Severe Sickle Cell Disease, ßS/ßC GenotypeSickle cell anaemiaMedDRA version: 21.0Level: PTClassification code: 10040641Term: Sickle cell anaemia Class: 100000004850CTIS2023-503247-34-00Vertex Pharmaceuticals Inc.14
进行中(未招募)
1 期
A study to evaluate the effects of Nexium in Children with Erosive Esophagitis (EE)Erosive EsophagitisMedDRA version: 20.1Level: LLTClassification code 10063657Term: Erosive esophagitisSystem Organ Class: 100000004856EUCTR2020-002515-21-ESAstraZeneca AB100
